Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05674435

Clinical Utility of Neuromodulation on Tinnitus

Conditions: Tinnitus

Sex: All
Ages: 18 Years – 65 Years
Enrollment: 26
Sponsor: Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

Location: Taiwan

Summary

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Eligibility Criteria

Inclusion Criteria:Tinnitus patientsAt least one of the neurofeedback methodsSingle and multi-centerRandomized control trials and observational studiesExclusion Criteria:Non-peer-reviewed papers, letters, editorialsNot English language

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05674435). StuddyBuddy aggregates publicly available trial information.